Study data suggest Medtronic’s Endurant AAA stent graft system for endovascular repair of abdominal aortic aneurysms, continues to deliver durable, consistent and proven outcomes.
Medtronic
Studies Presented at AHA Conclude CRT Therapy Extends Life, Reduces Hospital Readmissions
New data point to the clinical and economic value of Medtronic’s cardiac resynchronization therapy devices for the treatment of heart failure.
Medtronic Points to Improved Deliverability with EU Launch of Resolute Onyx™ DES
First and Only DES with Novel CoreWire Technology Allows for Thinner, Stronger Struts, Enhanced Deliverability and Radiopacity without Compromising Structural Strength
Integra Completes Acquisition of ENT Lines from Medtronic
Integra LifeSciences Holdings Corporation has completed the acquisition of the MicroFrance and Xomed instrument lines from Medtronic.
Pacing Lead Approval for MR-Conditional Use in Bradycardia Patients
The U.S. FDA has approved Medtronic’s CapSureFix Novus™ MRI SureScan® 5076 Lead for use with magnetic resonance imaging.
CoreValve Safe and Effective for Direct Aortic Approach
Study of 100 patients demonstrated low rates of mortality, stroke and paravalvular leak at 30 days.
Medtronic’s Kyphon Express™ II Increases Vertebral Fracture Treatment Options
Medtronic, Inc. has launched the KYPHON Express™ II Balloon Kyphoplasty Platform, which includes the next generation KYPHON® Cement Delivery System.
CE Mark and First US Implant for Medtronic’s Re-Sheathable CoreValve
Medtronic has gained CE Mark approval for the 23 mm CoreValve® Evolut™ R TAVI System and has seen the device’s first implantation in its U.S. study.
FDA Clears Medtronic SHILLA™ Growth Guidance System
Medtronic has gained U.S. FDA 510(k) clearance for its SHILLA™ Growth Guidance System, designed to treat spinal deformities in skeletally immature pediatric patients with severe, progressive, life-threatening, early-onset spinal deformities.
Medtronic Bolts on Sapiens Steering Brain Stimulation for $200 Million
Medtech Titan Medtronic has acquired Dutch Neuro device developer and its novel Deep Brain Stimulation system
FDA Approval for Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker
CE marked earlier in the year, Medtronic’s Viva CRT-P system will now be available for US patients following its newly announced FDA approval.
FDA Approval for Medtronic Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds
Medtronic’s new Performa® Quadripolar Lead and Viva® Quad CRT-Ds claims optimal and efficient Cardiac Resynchronization Therapy
Medtronic Boosts Neuro Portfolio with MIS Imaging Acquisition
Medtronic, Inc. has completed the acquisition of Visualase, Inc., and its FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgery.
Newly Approved Prestige® LP Moves Cervical Disc Game On
Medtronic has based its new device on the design principles of its successful predecessor, but a few changes of approach and material represent evolutionary steps.
FDA Class I Recall for Medtronic Duet External Drainage and Monitoring System
The Medtronic Duet External Drainage and Monitoring System is now the subject of a Class I recall because of concerns that tubing may separate, with serious consequences for patients.
TAVI Pendulum Swings Back Edwards Way as Sapien XT Gets FDA Approval
After its main competitor gained approval last week, now Edwards has its own reason to celebrate as the next generation Sapien XT gets the FDA’s nod.